İstanbul University, İstanbul Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology, İstanbul, Turkey
İstanbul University, İstanbul Faculty of Medicine, Department of Pediatric Surgery, İstanbul, Turkey
J Clin Res Pediatr Endocrinol. 2022 Mar 3;14(1):119-125. doi: 10.4274/jcrpe.galenos.2020.2020.0178. Epub 2021 Jan 15.
Papillary thyroid cancer (PTC) is extremely rare in children. Herein, we present a case diagnosed with PTC at 15 months of age. We conducted a literature review of the published cases with PTC under five years of age. A 1.25-year-old male patient had initially presented with a complaint of progressively enlarging cervical mass that appeared four months earlier. On physical examination, a mass located in the anterior cervical region with the largest measurements of around 3x3 cm was detected. Cervical and thyroid ultrasonography showed a 50x27 mm solid mass in the right lateral neck. Excisional biopsy revealed a follicular variant of PTC with capsular invasion. Subsequently, he underwent a complementary total thyroidectomy. He was diagnosed with intermediate-risk (T3N0M0) PTC. He developed permanent hypoparathyroidism. In the first year of the operation, he was treated with radioiodine ablation (RAI) since basal and stimulated thyroglobulin (Tg) levels tended to increase. Whole-body scintigraphy was normal in the first year of RAI ablation. On levothyroxine sodium (LT4) treatment, levels of thyroid stimulating hormone (TSH) and Tg were adequately suppressed. He is now 8.5-years-old and disease-free on LT4 replacement therapy for seven years and three months. Pediatric PTC has different biological behavior and an excellent prognosis compared to adults. The optimal treatment strategy for pediatric TC is total thyroidectomy, followed by RAI ablation. Post-operative management should include regular follow-up, TSH suppression by adequate LT4 therapy, serial Tg evaluation, and radioiodine scanning when indicated.
甲状腺乳头状癌(PTC)在儿童中极为罕见。在此,我们报告了一例 15 个月龄确诊为 PTC 的病例。我们对 5 岁以下 PTC 发表病例进行了文献回顾。一名 1.25 岁男性患儿最初因 4 个月前逐渐增大的颈肿块就诊。体格检查发现颈前区有一肿块,最大径约 3x3cm。颈部和甲状腺超声显示右侧颈部外侧有一 50x27mm 的实性肿块。切除活检显示为具有包膜侵犯的滤泡型 PTC。随后,他接受了补充性全甲状腺切除术。他被诊断为中危(T3N0M0)PTC。他发生了永久性甲状旁腺功能减退症。术后第一年,由于基础和刺激甲状腺球蛋白(Tg)水平升高,他接受了放射性碘消融(RAI)治疗。RAI 消融后第一年全身闪烁扫描正常。在左甲状腺素钠(LT4)治疗下,甲状腺刺激激素(TSH)和 Tg 水平得到充分抑制。他现在 8.5 岁,在 LT4 替代治疗下无病生存 7 年零 3 个月。与成人相比,儿童 PTC 具有不同的生物学行为和良好的预后。儿童 TC 的最佳治疗策略是全甲状腺切除术,随后进行 RAI 消融。术后管理应包括定期随访、通过充分的 LT4 治疗抑制 TSH、定期评估 Tg 以及在需要时进行放射性碘扫描。